Regulatory Expertise R3LS specializes in regulatory and compliance navigation from pre-clinical to commercialization, presenting a value proposition to biotech firms seeking expert CMC support and IND readiness.

Big Firm Capability, Small Firm With a boutique team of 2-10 employees and references to top-tier capabilities, position R3LS as a nimble alternative for companies that need customized, cost-efficient regulatory CMC consulting without sacrificing depth.

Therapy Modality Versatility Testimonials highlight proficiency across multiple pharmaceutical modalities, suggesting cross-sell opportunities into cell therapy and other advanced modalities that require specialized regulatory strategies.

Growth Enablement Current revenue under one million dollars, indicating an opportunity to upsell scalable consulting services, pricing packages, and ongoing compliance support as client programs mature.

Tech + Trust Utilize existing tech stack (Wix, Microsoft 365, Google Cloud) to enable client portals, document management, and collaboration tools that can improve IND/CMC submission workflows and accelerate project delivery.